COMPASS Pathways plc (CMPS)
13.27
-0.02 (0.15%)
Upcoming Events
Latest Headlines
AWARD ANNOUNCEMENT: One Mind Grants $1.5M to Rising Star Mental Health Researchers, Advancing Breakthrough Science and the Next Generation of Scientific Leaders
August 25, 2026 9:05 AM - BizWire
FESTIVAL ANNOUNCEMENT: 32nd Annual One Mind Music Festival Presented by Bank of America and Bristol Myers Squibb
August 19, 2026 9:05 AM - BizWire
/C O R R E C T I O N -- The Galien Foundation/
August 17, 2026 4:14 AM - PR NewsWire
The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and &q
August 13, 2026 9:00 AM - PR NewsWire
Stifel on Compass Pathways: 'remains on-track to complete the rolling NDA submission for COMP360 in 4Q'
August 12, 2026 4:36 PM - StreetInsider
Form 144 COMPASS Pathways plc Filed by: Jenkins Annalisa
August 10, 2026 1:27 PM - SEC Filing
Form 144 COMPASS Pathways plc Filed by: Jenkins Annalisa
August 7, 2026 11:36 AM - SEC Filing
Compass Pathways (CMPS) PT Raised to $22 at B.Riley
August 6, 2026 9:11 AM - StreetInsider
Compass Pathways (CMPS) PT Raised to $18 at Morgan Stanley
August 6, 2026 8:50 AM - StreetInsider
Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026
August 6, 2026 7:00 AM - BizWire
Compass Pathways (CMPS) PT Lowered to $21 at RBC Capital
August 6, 2026 6:44 AM - StreetInsider
Compass Pathways to supply psilocybin for VA veteran depression trial
August 6, 2026 6:30 AM - StreetInsider
Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin
August 6, 2026 6:30 AM - BizWire
COMPASS Pathways plc (CMPS) files mixed shelf
August 5, 2026 4:38 PM - StreetInsider
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 5, 2026 4:30 PM - BizWire
Form 4 COMPASS Pathways plc For: Aug 03 Filed by: Nath Kabir
August 5, 2026 4:23 PM - SEC Filing
Form S-3ASR COMPASS Pathways plc
August 5, 2026 4:05 PM - SEC Filing
Oppenheimer on Compass Pathways (CMPS): 'we see increasing focus on additional COMP360 opportunities beyond TRD'
August 5, 2026 2:17 PM - StreetInsider
Helus Pharma names ex-Intra-Cellular president as CEO
August 5, 2026 10:26 AM - StreetInsider
A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout
August 5, 2026 10:25 AM - Globe NewsWire
Form 8-K COMPASS Pathways plc For: Aug 05
August 5, 2026 6:31 AM - SEC Filing
Form 10-Q COMPASS Pathways plc For: Jun 30
August 5, 2026 6:31 AM - SEC Filing
Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
August 5, 2026 6:30 AM - BizWire
Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026
July 29, 2026 6:30 AM - BizWire
Wells Fargo sees psychedelics market reaching $11B by 2035
July 27, 2026 6:55 AM - StreetInsider
Wells Fargo Starts Compass Pathways (CMPS) at Equal Weight
July 27, 2026 5:44 AM - StreetInsider
B.Riley Reiterates Buy Rating on Compass Pathways (CMPS)
July 20, 2026 7:10 AM - StreetInsider
Compass Pathways study finds COMP360 support differs from psychotherapy
July 16, 2026 6:35 AM - StreetInsider
Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction of COMP360 Trial Monitoring & Support from Psychotherapy
July 16, 2026 6:35 AM - BizWire
FDA sets public hearing on psychedelics for September 14, Jefferies sees FDA willing to move on COMP360
July 13, 2026 1:04 PM - StreetInsider
TD Cowen Reiterates Buy Rating on Compass Pathways (CMPS)
July 13, 2026 6:26 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Compass Pathways (CMPS)
July 9, 2026 6:49 AM - StreetInsider
Evercore ISI Upgrades Compass Pathways (CMPS) to Outperform
July 8, 2026 9:42 AM - StreetInsider
Canaccord Reiterates Buy Rating on Compass Pathways (CMPS)
July 8, 2026 6:49 AM - StreetInsider
Compass Pathways (CMPS) PT Raised to $21 at Stifel
July 7, 2026 4:33 PM - StreetInsider
TD Cowen on Compass Pathways (CMPS): 'We think DEA reclassification to schedule 3 after approval is likely'
July 7, 2026 3:53 PM - StreetInsider
Wolfe Research on Compass Pathways (CMPS): 'we expect the stock to regain strong momentum after this pullback'
July 7, 2026 3:52 PM - StreetInsider
Oppenheimer on Compass Pathways (CMPS): 'Reinforced Durability Strengthens Launch Prospects'
July 7, 2026 12:11 PM - StreetInsider
Compass Pathways (CMPS) PT Raised to $25 at BTIG, 'executed nearly flawlessly on everything within its control'
July 7, 2026 12:10 PM - StreetInsider
Jefferies on Compass Pathways (CMPS): 'We remain 75-85%+ confident the FDA approves COMP360 (oral psilocybin) around YE:26/early 2027'
July 7, 2026 10:26 AM - StreetInsider
Form 8-K COMPASS Pathways plc For: Jul 07
July 7, 2026 6:33 AM - SEC Filing
Compass Pathways reports 6-month data from second psilocybin Phase 3 trial
July 7, 2026 6:30 AM - StreetInsider
Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile
July 7, 2026 6:30 AM - BizWire
Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026
July 6, 2026 8:30 AM - Globe NewsWire
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 2, 2026 6:30 AM - BizWire
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
June 30, 2026 9:00 AM - StreetInsider
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer
June 29, 2026 7:30 AM - Globe NewsWire
Compass Pathways (CMPS) PT Raised to $20 at Canaccord
June 26, 2026 7:37 AM - StreetInsider
Full Article List
